Tourniquet Hypertension

2

Review clinical trials related to Tourniquet Hypertension. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Long Axis Approach to the Femoral Artery Block (FAB) for Managing Tourniquet Pain and Hypertension in Below-the-Knee Fracture Surgery

This is a prospective, randomized, double-blind controlled trial evaluating an ultrasound-guided femoral artery block (FAB) using a long-axis in-plane approach compared with a short-axis approach and a control group. The study will include adult patients (ASA I-III) undergoing below-the-knee fracture surgery with tourniquet application. All patients will receive standardized anesthesia including sciatic nerve block and total intravenous anesthesia. Participants will be randomized into three groups: short-axis FAB, long-axis FAB, or control (saline injection). The primary aim is to assess the effectiveness of the long-axis FAB in reducing tourniquet-induced hypertension. Secondary outcomes include hemodynamic stability, analgesic requirements, pain scores, block characteristics, and procedural performance metrics.

Participants needed: 84
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: National and Kapodistrian University of AthensUpdated: Apr 30, 2026
Eligibility criteria

Age >18 years [+4]

Refusal to participate [+8]

Status: Recruiting

Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension

The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time.

Participants needed: 40
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Duke UniversityUpdated: Mar 23, 2026Locations: 1
Eligibility criteria

ASA 4 or 5 [+11]